AGTC Genomics

01/02/2026

🎗️ 𝗖𝗲𝗿𝘃𝗶𝗰𝗮𝗹 𝗰𝗮𝗻𝗰𝗲𝗿 𝗱𝗼𝗲𝘀𝗻’𝘁 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝗶𝘁𝘀𝗲𝗹𝗳 𝗹𝗼𝘂𝗱𝗹𝘆.
It doesn’t always come with pain.
It often starts silently.

And that’s exactly why early screening matters.

Cervical cancer is one of the most preventable cancers we know today — yet many women are still diagnosed too late, not because screening doesn’t work, but because it’s delayed or avoided.

🧠 The truth is simple:
✔️ Early screening can detect changes before cancer develops
✔️ When detected early, treatment is highly effective
✔️ Waiting for symptoms often means waiting too long

This isn’t just a women’s health issue.
It’s a family issue.
A community issue.
A public health responsibility.

If you are eligible for screening — don’t postpone it.
If you have women in your life — encourage the conversation.
If you work in healthcare, policy, or advocacy — amplify the message.

• A simple screening can save a life.
• Early detection saves lives.

Let’s normalize prevention.
Let’s replace fear with facts.
Let’s act before it’s too late.

30/01/2026

🧬 𝗝𝗼𝗶𝗻 𝗨𝘀: 𝗙𝗿𝗼𝗺 𝗥𝗡𝗔 𝘁𝗼 𝗥𝗲𝗮𝗱𝘀 – 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗻𝗴 𝗥𝗡𝗔-𝘀𝗲𝗾 𝗗𝗮𝘁𝗮 𝘁𝗼 𝗕𝗶𝗼𝗹𝗼𝗴𝘆

From raw sequencing reads to real biological meaning — RNA-seq can be incredibly powerful when designed and interpreted correctly.

You’re invited to our upcoming webinar, From RNA to Reads: Connecting RNA-seq Data to Biology. Join Dr Chrystine, Senior Scientific & Medical Liaison at AGTC Genomics, as she shares practical insights on how to turn RNA-seq data into meaningful biological understanding.

🔍 What you’ll learn:

Key considerations in RNA-seq study design

Common pitfalls and how to avoid them

Best practices to ensure RNA-seq experiments are fit for purpose

📅 Date: 5 February 2026 (Thursday)
⏰ Time: 3:00 – 3:30 PM
💻 Platform: Microsoft Teams

Whether you’re planning an RNA-seq project, analysing transcriptomic data, or translating results into biology, this session will be highly relevant.

👉 Register now:
69d62361-cf0a-431c-92a0-9e242eb11325@f9771754-e014-4ebe-81de-7498bca6b7d0" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/69d62361-cf0a-431c-92a0-9e242eb11325@f9771754-e014-4ebe-81de-7498bca6b7d0

30/01/2026

🧬 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗼𝗻𝗹𝘆 𝘀𝗲𝗲𝗶𝗻𝗴 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗴𝗲𝗻𝗲 𝗲𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝘀𝘁𝗼𝗿𝘆?

Many studies focus solely on mRNA, yet critical regulatory signals often come from non-coding RNAs, alternative splicing, and complex transcriptional events that remain hidden with targeted approaches. When research questions involve gene regulation, networks, or novel transcripts, partial views can lead to incomplete conclusions.

This is where Whole Transcriptomics Sequencing (WTS) unlocks the full picture.

At AGTC Genomics, our WTS service captures the entire transcriptome—from mRNA and lncRNA to circRNA—providing a comprehensive view of gene expression, regulatory mechanisms, and transcriptional complexity in a single experiment.

🔍 How does WTS help answer your research questions?
Whole Transcriptomics Sequencing is widely applied in:

• Cancer and complex disease research

• Gene regulation and signaling pathway studies

• Alternative splicing and fusion transcript discovery

• Biomarker discovery and translational research

• Systems biology and network-level analysis

📊 From raw RNA to biological insight
AGTC Genomics delivers end-to-end bioinformatics analysis, including expression quantification, differential gene expression, correlation analysis, and pathway enrichment (KEGG)—supported by PhD-level scientific project management to ensure high-quality data interpretation and meaningful outcomes.

🚀 If your research demands a complete, unbiased view of transcriptional activity, Whole Transcriptomics Sequencing provides the depth and breadth needed for discovery.

👉 Let’s see the transcriptome in full.
Contact AGTC Genomics today for a free consultation and discover how we can support and accelerate your research journey.

30/01/2026

🦠 𝗪𝗵𝗲𝗻 𝘀𝗽𝗲𝗰𝗶𝗲𝘀-𝗹𝗲𝘃𝗲𝗹 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗶𝘀𝗻’𝘁 𝗲𝗻𝗼𝘂𝗴𝗵, 𝗵𝗼𝘄 𝗱𝗲𝗲𝗽 𝗱𝗼 𝘆𝗼𝘂 𝗻𝗲𝗲𝗱 𝘁𝗼 𝗴𝗼?

In outbreak investigations, antimicrobial resistance research, and microbial evolution studies, knowing what organism is present is only the beginning. The real answers lie at the strain level, within virulence factors, resistance genes, and genome architecture that traditional methods often miss.

This is where Microbial Whole Genome Sequencing (WGS) delivers complete clarity.

At AGTC Genomics, our microbial WGS service provides full genome coverage with the highest possible resolution, enabling precise strain identification, de novo genome assembly, and comprehensive profiling of virulence and antimicrobial resistance (AMR) genes—all within a single workflow.

🔬 How does microbial WGS solve your research questions?
Microbial Whole Genome Sequencing is widely applied in:

• Outbreak investigation & infection control

• Antimicrobial resistance (AMR) surveillance

• Strain typing and phylogenetic analysis

• Pathogen evolution & virulence studies

• New microbial species discovery in clinical, environmental, food, and agricultural settings

📊 From raw reads to actionable microbial insights
AGTC Genomics offers both reference-based re-sequencing and high-quality de novo assembly, including gene prediction, virulence profiling, and AMR gene annotation—supported by PhD-level scientific project management to ensure robust interpretation and confident decision-making.

🚀 If your research demands complete microbial genomes and complete confidence, Microbial WGS is the gold standard.

👉 Let’s decode your microbes—base by base.
Contact AGTC Genomics today for a free consultation and discover how we can support and accelerate your research journey.

29/01/2026

𝗔𝗡𝗡𝗢𝗨𝗡𝗖𝗘𝗠𝗘𝗡𝗧 | 𝗔𝗚𝗧𝗖 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝘄𝗶𝘁𝗵 𝗚𝗲𝗻𝗲𝗠𝗶𝗻𝗱 𝗮𝗻𝗱 𝗜𝗻𝘁𝗲𝗿𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝘁𝗼 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗶𝗻 𝗦𝗼𝘂𝘁𝗵𝗲𝗮𝘀𝘁 𝗔𝘀𝗶𝗮

We are proud to announce a strategic partnership between AGTC Genomics, GeneMind Biosciences, and Interscience Sdn Bhd to accelerate the next phase of precision medicine and genomic innovation in Southeast Asia.

As one of the largest genomics sequencing facilities in the region, AGTC Genomics operates a clinical-grade, high-throughput NGS laboratory that supports both routine clinical diagnostics and large-scale R&D and genome research. Our lab is ISO 15189, ISO 17025, and CAP-accredited, reflecting our commitment to international quality and regulatory standards.

Together with GeneMind’s advanced sequencing technologies and Interscience’s strong research and scientific ecosystem, this partnership strengthens a regional genomics infrastructure that bridges:

🔹 Clinical diagnostics

🔹 Translational and population genomics

🔹 Pharmaceutical and biomedical R&D

This collaboration positions AGTC Genomics to capture long-term growth opportunities in one of the world’s fastest-growing healthcare and biotech markets, while delivering meaningful impact to patients, clinicians, and researchers.

📈 Precision medicine is no longer a future concept — it is becoming core healthcare infrastructure.

We look forward to building this ecosystem together.

AGTC Genomics Partners with GeneMind and Interscience to Accelerate Precision Medicine and Genomic Innovation in Southeast Asia

29/01/2026

🧬 𝗪𝗵𝘆 𝗱𝗼 𝗺𝗮𝗻𝘆 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 𝘀𝘁𝗶𝗹𝗹 𝗰𝗼𝗺𝗲 𝘂𝗽 𝗲𝗺𝗽𝘁𝘆—𝗲𝘃𝗲𝗻 𝘄𝗵𝗲𝗻 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗰𝗹𝗲𝗮𝗿𝗹𝘆 𝗿𝘂𝗻𝘀 𝗶𝗻 𝗳𝗮𝗺𝗶𝗹𝗶𝗲𝘀?

In most rare diseases and many cancers, the majority of clinically relevant mutations sit within protein-coding regions of the genome. Whole-genome sequencing can be powerful, but it is often unnecessary and costly when the research question is focused on functional variants.

This is where Whole Exome Sequencing (WES) provides the ideal balance.

At AGTC Genomics, our WES service delivers deep, uniform coverage across all exons, enabling sensitive detection of SNPs, INDELs, CNVs, and somatic mutations—precisely where most disease-associated variants are found.

🔍 How does WES help answer your research questions?
Whole Exome Sequencing is widely applied in:

• Rare disease and undiagnosed disorder studies

• Cancer genomics and somatic variant discovery

• Population and familial genetics research

• Gene discovery and variant prioritization

• Cost-effective large-scale genomic studies

📊 From sequence data to biological meaning
AGTC Genomics provides end-to-end bioinformatics analysis, including reference-based alignment, variant calling, and annotation—supported by PhD-level scientific project management to ensure robust study design, high-quality data, and confident interpretation.

🚀 If your research requires high-sensitivity variant discovery without the cost of whole-genome sequencing, Whole Exome Sequencing is a proven and powerful approach.

👉 Let’s uncover the variants that matter most.
Contact AGTC Genomics today for a free consultation and discover how we can support and accelerate your research journey.

29/01/2026

🧬 𝗪𝗵𝗲𝗻 𝗲𝘅𝗼𝗺𝗲 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗶𝘀𝗻’𝘁 𝗲𝗻𝗼𝘂𝗴𝗵, 𝘄𝗵𝗲𝗿𝗲 𝗱𝗼 𝘁𝗵𝗲 𝗮𝗻𝘀𝘄𝗲𝗿𝘀 𝗹𝗶𝗲?

Many complex diseases, rare conditions, and population traits cannot be fully explained by coding regions alone. Critical variants often sit in non-coding, regulatory, or structural regions of the genome—remaining invisible to targeted approaches.

This is where Human Whole Genome Sequencing (WGS) delivers unmatched insight.

At AGTC Genomics, our WGS service provides a complete, unbiased view of the human genome, capturing both coding and non-coding regions in a single assay. This enables researchers to uncover SNPs, INDELs, CNVs, and structural variants, as well as novel and regulatory mutations that drive disease biology.

🔍 How does WGS help answer your research questions?
Whole Genome Sequencing is widely applied in:

• Rare disease discovery and unresolved diagnostic cases

• Cancer and oncology research, including structural and regulatory variants

• Population genomics & diversity studies

• Complex trait and polygenic architecture research

• Discovery of novel variants beyond the exome

📊 From raw genome data to biological meaning
AGTC Genomics delivers end-to-end bioinformatics analysis, including reference-based alignment, variant calling, and annotation—supported by PhD-level scientific project management to ensure high-quality, interpretable, and publication-ready results.

🚀 If your research demands the most comprehensive genetic resolution available, Whole Genome Sequencing is the gold standard.

👉 Let’s explore the genome without blind spots.
Contact AGTC Genomics today for a free consultation and discover how we can support and accelerate your research journey.

28/01/2026

🧫 𝗔𝗿𝗲 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗺𝗲𝘁𝗵𝗼𝗱𝘀 𝗹𝗶𝗺𝗶𝘁𝗶𝗻𝗴 𝘄𝗵𝗮𝘁 𝘆𝗼𝘂 𝗰𝗮𝗻 𝘀𝗲𝗲 𝗶𝗻 𝗰𝗼𝗺𝗽𝗹𝗲𝘅 𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗮𝗹 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝗶𝗲𝘀?

When bacteria, fungi, viruses, and archaea coexist in the same sample, targeted or amplicon-based approaches can introduce bias and miss critical organisms or functions. For researchers asking what is really there and what it is doing, a broader, unbiased view is essential.

This is where Shotgun Metagenomics Sequencing makes the difference.

At AGTC Genomics, our shotgun metagenomics service delivers complete, untargeted microbial and functional profiling in a single workflow—capturing species and strain-level resolution, resistomes, and metabolic potential without prior assumptions.

🔬 How does shotgun metagenomics help answer your research questions?
This approach is widely applied in:

• Gut microbiome & human health research

• Environmental and soil microbiome studies

• Antimicrobial resistance (AMR) and resistome surveillance

• Food safety, fermentation, and industrial microbiology

• Pathogen discovery and complex outbreak investigations

📊 From raw reads to functional insight
AGTC Genomics provides comprehensive bioinformatics analysis, from taxonomic profiling to metagenome assembly and functional annotation (KEGG, eggNOG, CAZy), supported by PhD-level scientific project management to ensure high-quality, interpretable, and actionable results.

🚀 If your research demands no bias, no blind spots, and no limits, shotgun metagenomics is the gold standard.

👉 Let’s explore your microbiome in full resolution.
Contact AGTC Genomics today for a free consultation and discover how we can support and accelerate your research journey.

28/01/2026

🧠 𝗛𝗼𝘄 𝗱𝗼 𝘄𝗲 𝘂𝗻𝗰𝗼𝘃𝗲𝗿 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗿𝗶𝘀𝗸 𝗮𝘁 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝘀𝗰𝗮𝗹𝗲—𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗲𝗻𝘁𝗶𝗿𝗲 𝗴𝗲𝗻𝗼𝗺𝗲𝘀?

For large cohorts, biobanks, and epidemiological studies, whole-genome sequencing can be unnecessarily expensive and time-consuming when the key question is about known genetic variants and their association with disease or traits.

This is where Human Genotyping Arrays provide a powerful and practical solution.

At AGTC Genomics, our human genotyping array service enables high-throughput, cost-effective genome-wide genotyping, allowing researchers to screen hundreds of thousands to millions of SNPs with high accuracy and consistency—ideal for studies that demand scale, speed, and reproducibility.

🔍 How does this support your research questions?
Human genotyping arrays are widely used in:

• Genome-Wide Association Studies (GWAS) for disease risk and trait discovery

• Population genetics & cohort studies

• Polygenic risk score (PRS) development and validation

• Pharmacogenomics & drug-response studies

• Biobank and large-scale translational research

📊 From array data to actionable insights
AGTC Genomics delivers standardized array processing, genotype and variant calling, and structured data outputs—backed by PhD-level scientific project management to ensure your study design, analysis, and interpretation are robust and publication-ready.

🚀 If your research requires large-scale genetic insights without the cost burden of sequencing, human genotyping arrays offer the optimal balance between depth, throughput, and efficiency.

👉 Let’s scale your genetics study with confidence.
Contact AGTC Genomics today for a free consultation and discover how we can support and accelerate your research journey.

Call now to connect with business.

28/01/2026

🌸 𝗪𝗘𝗕𝗜𝗡𝗔𝗥 | 𝗚𝗹𝗼𝗯𝗮𝗹 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗕𝗿𝗲𝗮𝗸𝗳𝗮𝘀𝘁 𝟮𝟬𝟮𝟲 🌸

𝗠𝗮𝗻𝘆 𝗩𝗼𝗶𝗰𝗲𝘀, 𝗢𝗻𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲

In conjunction with the IUPAC Global Women’s Breakfast 2026, we are pleased to invite you to a special webinar celebrating diversity, collaboration, and shared purpose in science.

This session brings together scientists and leaders from different disciplines and backgrounds to reflect on how many voices can come together to advance one science — strengthening innovation, inclusivity, and impact across the scientific community.

📅 Date: 10 February 2026 (Tuesday)
⏰ Time: 11:00 AM – 12:00 PM
💻 Platform: Online (Zoom)

🎙 𝗠𝗼𝗱𝗲𝗿𝗮𝘁𝗼𝗿
• CHM Dr. Sheela Chandren – ACS Malaysia Chapter

👩‍🔬👨‍🔬 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀
• Ts. CHM Dr. Mohamad Shazeli Che Zain – Phytochemist & Senior Lecturer, USM
• Prof. Leong Chee-Onn – Cancer Biologist & Scientific Leader, CEO, AGTC Genomics
• Ts. CHM Dr. Hj. Rozzeta Dolah – Nanotechnologist, Technopreneur, Senior Lecturer, UTM; Managing Director, Zetatech

Organised by Institut Kimia Malaysia (IKM), co-organised with ACS Malaysia Chapter, and supported by universities and scientific organisations nationwide.

✨ Let’s connect, learn, and celebrate the role of women — and allies — in shaping the future of science.

🔗 Scan the QR code on the poster to register
📌 All are welcome

IUPAC Global Women’s Breakfast 2026

27/01/2026

🤝𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝗚𝗲𝗻𝗼𝗺𝗶𝗰 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗚𝗲𝗻𝗲𝗠𝗶𝗻𝗱 𝗖𝗵𝗶𝗻𝗮

A sincere thank you to GeneMind Biosciences (Shenzhen, China) for welcoming the AGTC Genomics team during our recent visit. It was an inspiring opportunity to exchange ideas and explore the forefront of next-generation sequencing technology.

🔬 GeneMind’s innovation in high-throughput sequencing platforms, integrated automation, and bioinformatics aligns well with AGTC Genomics’ vision to advance genome research and technology development across Southeast Asia.

This visit marks the next step in a growing collaboration focused on:

📦 Technology transfer and adaptation of robust NGS systems to local research ecosystems

🧠 Combining GeneMind’s engineering and manufacturing strength with AGTC’s regional R&D and application expertise

🌏 Co-developing technology platforms that are scalable, localized, and capable of supporting the region’s growing genomics needs—from discovery to translational research

We look forward to deepening our partnership to support scientific communities and institutions across ASEAN in building sustainable, next-generation genomics capabilities.